| | |
---
Merck Withdraws Arthritis Drug Vioxx
Merck Withdraws Arthritis Drug Vioxx -- Posted by MrPepper11 on 09-30-04 08:01
Lesson: The newer the drug - and the more TV commercials - the less
data they have.
Associated Press 9/30/04
Merck Withdraws Arthritis Drug Vioxx
TRENTON, N.J. - Pharmaceutical giant Merck & Co. is pulling its
blockbuster arthritis drug Vioxx from the market worldwide because new
data from a clinical trial found an increased risk of heart attack and
stroke. Its stock price plunged more than 25 percent as the company
said the recall will hurt its earnings.
Merck said Thursday that data from the trial showed the increased risk
of heart attack and other cardiovascular complications began 18 months
after patients started taking Vioxx.
The data comes from a three-year study aimed at showing that Vioxx at
a 25 milligram dose prevents recurrence of polyps in the colon and
rectum. Such polyps can turn cancerous. The trial was stopped after
Merck discovered the higher heart risk compared to patients taking
dummy pills.
"It's a disaster for Merck, coming at the worst time," said
independent health care analyst Hemant Shah of HKS & Co. in Warren,
N.J.
Vioxx is one of Merck's most important drugs, with $2.5 billion in
sales in 2003. But sales dipped 18 percent in the second quarter of
this year to $653 million, partly due to increasing concerns about the
drug's safety.
"We're taking this action because we believe it best serves the
interest of patients," Ray V. Gilmartin, Merck's chairman, president
and chief executive, said in a prepared statement.
"Although we believe it would have been possible to continue to market
Vioxx with labeling that would incorporate these new data, given the
availability of alternative therapies and the questions raised by the
data, we concluded that a voluntary withdrawal is the responsible
course to take," he said.
Merck, the world's third-biggest drug maker, announced the news before
the stock market opened. In early trading on the New York Stock
Exchange, Merck shares plunged $11.40, or more than 25 percent, to
$33.67.
The analyst Shah said the withdrawal of Vioxx comes "at a time when
they really need to get ready for expiration" of its patent for Zocor,
a high cholesterol drug which is Merck's top-selling drug. Zocor loses
patent protection early in 2006 and sales are expected to plunge when
generic competition begins. In an effort to replace those revenues,
Merck recently launched a drug with partner Schering-Plough Corp.,
Vytorin, that combines Zocor and Schering-Plough's Zetia to attack
cholesterol levels in two complementary ways.
"This makes it almost inevitable for the company to find a merger
partner for them to continue to grow," Shah said.
Merck's announcement stands to benefit rival Pfizer Inc., the world's
biggest drug maker. The two companies have been battling for market
share, with Pfizer's Celebrex dominating the market with about $5
billion in U.S. sales alone last year. Pfizer shares were up 68 cents,
or more than 2 percent, to $30.86 in early trading on the NYSE.
"I think Celebrex sales are going to significantly increase," Shah
said.
Vioxx, launched in the United States in 1999, and a successor drug
called Arcoxia, approved in some other countries and awaiting Food and
Drug Administration approval here, are part of a class of
anti-inflammatory drugs heavily touted by the pharmaceutical industry
as being more effective and having less side effects, particularly on
the gastrointestinal system, than older drugs.
Pfizer's Celebrex and its successor drug, Bextra, which already is on
the market in the United States, also are in that class, called cox-2
inhibitors.
"This has never been the massive innovation which was promoted to be,"
Shah said of the drug class. "In terms of pain relief, these drugs are
no better than ibuprofen and they cost 10, 15 times more."
He said it is possible the news, along with some prior reports about
heart risk and gastrointestinal bleeding linked to the drugs, could
push some patients to go back to older, cheaper drugs.
Shah also said physicians prefer ibuprofen more than Celebrex and
Vioxx combined.
The company said the Vioxx recall will slash about 50 cents to 60
cents a share from its earnings for the rest of this year. That
includes foregone sales, writeoffs of inventory held by Merck,
customer returns of product previously sold and other costs of the
pullback. Merck expects foregone fourth quarter sales of Vioxx of $700
million to $750 million alone.
Merck, which is based in Whitehouse Station, N.J., had previously been
expecting 2004 earnings per share of $3.11 to $3.17.
Merck is scheduled to release financial results for the third quarter,
which ends today, on Oct. 21.
------------
On the Net: http://www.merck.com
Re: Merck Withdraws Arthritis Drug Vioxx -- Posted by Ilena Rose on 09-30-04 09:03
On 30 Sep 2004 08:01:27 -0700, MrPepper11@go.com (MrPepper11) wrote:
>"It's a disaster for Merck, coming at the worst time," said
>independent health care analyst Hemant Shah of HKS & Co. in Warren,
>N.J.
Thanks for posting this.
It appears to have been a "disaster" in the lives of many who paid big
money for this drug ... and also paid with their lives.
I believe the company kept these on the market for years after knowing
that these risks were there ...
Re: Merck Withdraws Arthritis Drug Vioxx -- Posted by R-g3 on 09-30-04 09:18
On Thu, 30 Sep 2004 10:03:02 -0600, Ilena Rose
wrote:
>
>It appears to have been a "disaster" in the lives of many who paid big
>money for this drug ... and also paid with their lives.
What kind of FDA is this?
What do they do? Rubberstamp whatever the drug company says?
Drug after drug - from antidepressants to antiinflammatories and
laxatives - have been advertised as technical wonders and miracle
cures...
And then ... "oops! we don't think this stuff is safe for ya..."
Re: Merck Withdraws Arthritis Drug Vioxx -- Posted by M*a*r*k P*r*o*b*e*r*t-September 30, 2004 on 09-30-04 10:28
"R-g3" wrote in message
news:n8col0tuo9ksldvi67s12vfs5om09d5qqa@4ax.com...
> On Thu, 30 Sep 2004 10:03:02 -0600, Ilena Rose
> wrote:
> >
> >It appears to have been a "disaster" in the lives of many who paid big
> >money for this drug ... and also paid with their lives.
>
> What kind of FDA is this?
> What do they do? Rubberstamp whatever the drug company says?
> Drug after drug - from antidepressants to antiinflammatories and
> laxatives - have been advertised as technical wonders and miracle
> cures...
> And then ... "oops! we don't think this stuff is safe for ya..."
Sometimes, a problem with a medication does not show up until the cohort is
very large. When it does show up, the medication is pulled.
Of course, if you are a mindless anti-medication, anti-science know nothing,
you won't understand this.
Re: Merck Withdraws Arthritis Drug Vioxx -- Posted by Pumbaa on 09-30-04 10:53
Isn't most medication tested and sold first in Europe, South America,
Africa, so forth where it is easier to get on the market. Are the sales of
new drugs overseas not large enough in quantity or the research so poorly
done that problems are not picked up before the drug is release to the USA
market? It seems we are all test animals for the drug companies who don't
even have to prove a drug is better than an existing product before they put
it on the market.
> "R-g3" wrote in message
> news:n8col0tuo9ksldvi67s12vfs5om09d5qqa@4ax.com...
> Sometimes, a problem with a medication does not show up until the cohort
is
> very large. When it does show up, the medication is pulled.
Re: Merck Withdraws Arthritis Drug Vioxx -- Posted by M*a*r*k P*r*o*b*e*r*t-September 30, 2004 on 09-30-04 11:46
"Pumbaa" wrote in message
news:cjhh7b02f9u@enews1.newsguy.com...
> Isn't most medication tested and sold first in Europe, South America,
> Africa, so forth where it is easier to get on the market.
Why not do some research and find out?
Are the sales of
> new drugs overseas not large enough in quantity or the research so poorly
> done that problems are not picked up before the drug is release to the USA
> market?
Why not do some research and find out?
It seems we are all test animals for the drug companies who don't
> even have to prove a drug is better than an existing product before they
put
> it on the market.
That is not the marketing standard. A pharmaceutical must be proven safe and
effective prior to marketing. Testing, which is VERY expensive sometimes
does not show a problem until the cohort is very large. In the Vioxx case,
it was a post marketing follow-up that found the problem.
> > "R-g3" wrote in message
> > news:n8col0tuo9ksldvi67s12vfs5om09d5qqa@4ax.com...
> > Sometimes, a problem with a medication does not show up until the cohort
> is
> > very large. When it does show up, the medication is pulled.
>
>
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next »
Related
Discussion:
NATURAL CURE FOR UROLOGY DISFUNCTIONS (2 posts)
by Samy Wang - Last post on: 02-01-04 10:23
This is a multi-part message in MIME format.
------=_NextPart_000_00CD_01C3E241.11A01000
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
--=20
SEXOLOGY & NATURAL CURE FOR UROLOGY DISFUNCTION THROUGH REFLEXOLOGY
Dear Sirs
We wish to ... (Read More)
Re: PROPOSAL: ALT.THYROID (1 posts)
by derjda@hotmail.com - Last post on: 12-08-04 11:29
have you been to alt.support.thyroid?
... (Read More)
Optimal Health (1 posts)
by AME - Last post on: 07-13-04 02:24
Stories are circulating about how Glyco-Nutrients (the eight essential
sugars for optimal health) have changed the lives of people suffering from
Asthma, Lupus, Hepatitis C, Rheumatoid Arthritis, Osteoarthritis; Crohn's
and Chronic Ulcerative Colitis, Fibromyalgia, Diabetes, CFS, Multiple
Sclero... (Read More)
Program Links Diabetic Kids With Doctors (1 posts)
by Gumbo - Last post on: 10-23-04 05:50
Program Links Diabetic Kids With Doctors
KANSAS CITY, Mo. - Diabetic 9-year-old Gabe Mathews had very low blood sugar
before a test, but hours later at home his mother found it to be far too
high.
Such swings are common for children with Type I diabetes, the rarer form of
the disease, whi... (Read More)
Top
Discussions From Our Archives
Massachusetts TCC Resource
Fading social life may signal trouble in diabetes
Traveling With Diabetes
Food, Culture, and Diabetes in the United States
Re: strongest vibrating phone
[Fwd: LYCOPENE AND HEART DISEASE]
Other
Discussion Categories
Diabetes Symptoms
Health Care Policy
Health Care Providers HMO
Arthritis Symptoms
Oops!!! Unexpected Error While Reading the Feed
|
|
